Last reviewed · How we verify
NCT05018624
Alcohol Brief Intervention Integrated With Mobile Chat-based Support for Risky Drinkers in Emergency Departments
NA trial testing Alcohol brief intervention in Alcohol Misuse in 632 participants. Completed in 31 March 2025.
30 September 2024
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 632 |
| Start date | 23 May 2022 |
| Primary completion | 30 September 2024 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Alcohol brief intervention
- 12-page health warning leaflet
- Regular messages through Instant Messaging (IM)
- Real-time chat-based support through IM Apps
- AUDIT score interpretation sheet adapted from the Department of Health of Hong Kong
Conditions studied
- Alcohol Misuse — all drugs for Alcohol Misuse →
Sponsor
The University of Hong Kong
Who can join
18 and older, any sex, with Alcohol Misuse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to assess the effectiveness of chat-based intervention on reducing risky alcohol consumption to inform clinical practice for providing ABI to risky drinkers attending AED in Hong Kong.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05018624
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Alcohol brief intervention
Trials testing the same drug.
- NCT04025151 — Nurse-led Alcohol Brief Intervention Plus Mobile Personalized Chat-based Support on Reducing Alcohol Use in University S · NA · unknown
- NCT03823599 — Alcohol Brief Intervention Plus Personalized Mobile Chat-based Intervention to Reduce Alcohol Misuse in an Emergency Dep · NA · completed
- NCT03675373 — Alcohol Brief Intervention Plus Personalized Mobile Chat-based Intervention for High-risk Drinking University Students · NA · completed
Other recruiting trials for Alcohol Misuse
Currently open trials in the same condition.
- NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
- NCT07132177 — Targeted Naltrexone to Support Individuals Participating in Dry January · Phase 2 · recruiting
- NCT07339150 — MiREA-AC for Reducing Problematic Alcohol and Marijuana Use in College Students · NA · recruiting
- NCT06778278 — Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans · NA · recruiting
- NCT07021053 — Adaptive Actions and Alcohol Use Outcomes During Internet-delivered Cognitive Behaviour Therapy · NA · recruiting
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05018624 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 1 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05018624.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing